<DOC>
	<DOCNO>NCT00887601</DOCNO>
	<brief_summary>This study evaluate functional magnetic resonance imaging ( fMRI ) method measure drug induce change cerebral blood flow biomarkers attention-improving drug .</brief_summary>
	<brief_title>BOLD Functional Magnetic Resonance Imaging ( fMRI ) Cerebral Blood Flow Measurements Biomarkers Cognition Enhancing Drugs ( 3134-006 )</brief_title>
	<detailed_description />
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<mesh_term>Nootropic Agents</mesh_term>
	<criteria>Subject nonsmoker Subject generally good health Subject normal ( correct normal ) vision hear Subject righthanded Subject history illness would make participation unsafe would make study result difficult interpret Subject history stroke , seizure , major neurological disorder Subject history cancer Subject permanent cosmetic metallic implant would interfere measurement Subject history sleep apnea Subject history head injury/trauma</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>